A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.

The value of chemotherapy in advanced non-small cell lung cancer (NSCLC) remains contentious. Because of this two separate but very similar trials were set up in Australia and Southampton (UK). Two hundred and one patients with stage IIIb or IV NSCLC were randomly assigned to cisplatin 120 mg m-2 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Woods, R. L., Williams, C. J., Levi, J., Page, J., Bell, D., Byrne, M., Kerestes, Z. L.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971367/
https://www.ncbi.nlm.nih.gov/pubmed/1691921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971367/
https://www.ncbi.nlm.nih.gov/pubmed/1691921

Ejemplares similares